Latest News and Press Releases

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist

MONACO, March 24, 2026 (GLOBE NEWSWIRE) -- From the preservation of ocean species to exploration on the Moon, from the study of underwater shipwrecks off the coast of Majorca to the oceans in space....

AIAA and Challenger Center announce 2026 Trailblazing STEM Educator Awards for three remarkable educators